| 000 | 01600 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250518030431.0 | ||
| 264 | 0 | _c20200210 | |
| 008 | 202002s 0 0 eng d | ||
| 022 | _a1090-2104 | ||
| 024 | 7 |
_a10.1016/j.bbrc.2019.03.020 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aWang, Xiaoyan | |
| 245 | 0 | 0 |
_aAnti-β _h[electronic resource] |
| 260 |
_bBiochemical and biophysical research communications _c04 2019 |
||
| 300 |
_a72-78 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntibodies, Antiphospholipid _xadministration & dosage |
| 650 | 0 | 4 |
_aAntiphospholipid Syndrome _xetiology |
| 650 | 0 | 4 |
_aApolipoproteins E _xdeficiency |
| 650 | 0 | 4 |
_aAtherosclerosis _xetiology |
| 650 | 0 | 4 | _aAutoimmunity |
| 650 | 0 | 4 |
_aDiet, High-Fat _xadverse effects |
| 650 | 0 | 4 | _aDisease Models, Animal |
| 650 | 0 | 4 |
_aImmunoglobulin G _xadministration & dosage |
| 650 | 0 | 4 |
_aMacrophages _xpathology |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMice, Knockout, ApoE |
| 650 | 0 | 4 |
_aPlaque, Atherosclerotic _xetiology |
| 650 | 0 | 4 |
_abeta 2-Glycoprotein I _xantagonists & inhibitors |
| 700 | 1 | _aZhu, Xiang | |
| 700 | 1 | _aZhou, Hong | |
| 700 | 1 | _aXia, Longfei | |
| 700 | 1 | _aWang, Ting | |
| 700 | 1 | _aWang, Zhongqun | |
| 700 | 1 | _aLi, Yuefeng | |
| 700 | 1 | _aYan, Jinchuan | |
| 700 | 1 | _aWang, Ting | |
| 773 | 0 |
_tBiochemical and biophysical research communications _gvol. 512 _gno. 1 _gp. 72-78 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.bbrc.2019.03.020 _zAvailable from publisher's website |
| 999 |
_c29477712 _d29477712 |
||